2019 annual financial data
Aquestive Therapeutics 2019 Operating cash flow margin
Direct answer
Operating cash flow margin was -114.45%.
Operating income was -52,668,000 USD and net income was -66,246,000 USD.
Operating cash flow was -60,210,000 USD.
Get free Aquestive Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 52,609,000 USD
- Operating income
- -52,668,000 USD
- Net income
- -66,246,000 USD
- Operating cash flow
- -60,210,000 USD